Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectives.

Current oncology reports

Volumn 3, Issue 4, 2001, Pages 359-367

  Eggermont, A M ^a   ten Hagen, T L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; MELPHALAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; FORECASTING; HUMAN; LIMB; METASTASIS; METHODOLOGY; PATHOLOGY; RAT; REGIONAL PERFUSION; REVIEW; SARCOMA; SOFT TISSUE TUMOR;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; EXTREMITIES; FORECASTING; HUMANS; MELPHALAN; NEOPLASM METASTASIS; RATS; SARCOMA; SOFT TISSUE NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035403040     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-001-0090-8     Document Type: Review

References (88)